Assyro AI

Orange Book product · Generic (ANDA)

CHOLINE C-11

CHOLINE C-11

Generic (ANDA)ANDA 208413DISCN WA UNIV SCH MED

At a glance

Jan 10, 2017

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 10, 2017

    9 yr 7 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CHOLINE C-11

Strength

4-33.1mCi/ML

Dosage form

INJECTABLE

Route

INTRAVENOUS

TE code

Not listed

Application

ANDA 208413

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CHOLINE C-11

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.